CaseBioscience is a biotechnology startup committed to providing high-quality solutions for the cell therapy and ART industries. With an ISO 13485:2016 certification, the company specializes in sterile media products, offering top-quality cGMP manufacturing services to drive advancements in Regenerative Medicine, Cell Therapy, and Assisted Reproductive Technology (ART). CaseBioscience focuses on developing innovative cryopreservation and culture technologies tailored for these sectors, leveraging their experience as a cGMP manufacturer to adhere to strict regulatory standards. Founded in 2021, the company has quickly positioned itself as a trusted partner in the industry, boasting extensive experience and reliability.
There is no investment information
No recent news or press coverage available for CaseBioscience.